FDA: Robert Califf confirmed as FDA’s Commissioner in narrow vote
Robert M. Califf, M.D., was sworn in as new Commissioner of the Food and Drugs Administration on February 17, 2022. He has previously served as Commissioner from February 2016 to January 2017, during President Obama’s final year in office.
Prior to rejoining the FDA, Robert Califf was head of medical strategy and Senior Advisor at Alphabet Inc. As a cardiologist, he brings along an extensive clinical research experience. However, a narrow 50 - 46 vote for him shows the controversy about his person, mainly centering around his “close” pharmaceutical industry ties. Janet Woodcock, who served as acting commissioner last year, has agreed to remain at the agency as his principal deputy commissioner. Find more details on Robert Califf here.
Source:
FDA: FDA Organization
Meet the GMP Compliance Adviser
The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.
The demo access is non-binding and ends automatically.
You may also be interested in the following articles:
